Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17,600
Frequently Asked Questions
What is Market Cap of Gilead Sciences, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gilead Sciences, Inc. market cap is $142.13B.
What is the 52-week high for Gilead Sciences, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. 52 week high is $121.83 as of September 15, 2025.
What is the 52-week low for Gilead Sciences, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. 52 week low is $81.83 as of September 15, 2025.
What is Gilead Sciences, Inc. stock price today?
Gilead Sciences, Inc. stock price today is $113.76.
What was Gilead Sciences, Inc. stock price yesterday?
Gilead Sciences, Inc. stock price yesterday was $117.05.
What is the PE ratio of Gilead Sciences, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gilead Sciences, Inc.’s P/E ratio is 22.79.
What is the Price-to-Book ratio of Gilead Sciences, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gilead Sciences, Inc. P/B ratio is 7.2314.
What is the 50-day moving average of Gilead Sciences, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gilead Sciences, Inc. 50-day moving average is $114.01.
How many employess does Gilead Sciences, Inc. has?
GILD Gilead Sciences, Inc.